Total medical devices industry M&A deals worth $23.26bn were announced globally in January 2021, led by OptumInsight’s $13bn acquisition of Change Healthcare, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 255.1% over the previous month of $6.55bn and a rise of 317.6% when compared with the last 12-month average, which stood at $5.57bn.
Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $21.21bn. At the country level, the US topped the list in terms of deal value at $21.21bn.
In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Middle East and Africa.
The top country in terms of M&A deals activity in January 2021 was the US with 25 deals, followed by the Germany with three and Israel with three.
In 2021, as of January, medical devices M&A deals worth $23.26bn were announced globally, marking an increase of 1206.4% year on year.
medical devices industry M&A deals in January 2021: Top deals
The top five M&A deals accounted for 87.5% of the overall value during January 2021.
The combined value of the top five medical devices M&A deals stood at $20.34bn, against the overall value of $23.26bn recorded for the month.
The top five medical devices industry M&A deals of January 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition of Cantel Medical by Steris
3) Boston Scientific’s $1.23bn acquisition of Preventice
4) The $880.85m asset transaction with Novasep Holding by Thermo Fisher Scientific
5) Koninklijke Philips’ acquisition of Capsule Technologies for $635m.